Health Insurance Marketplace Open Enrollment Through Dec. 15

2018-11-09T22:35:10+00:00 November 9th, 2018|

Now is the time to renew health insurance coverage purchased through a state or federal health insurance marketplace, also known as an insurance exchange. Marketplace open enrollment has begun and continues through Dec. 15. The federal government website - - has tools to sign up for new coverage, change plans or renew coverage for

Choose Your 2019 Medicare Coverage Through Dec. 7

2018-10-19T21:11:06+00:00 October 19th, 2018|

Medicare open enrollment, also called annual enrollment, has begun and continues through Dec. 7. During open enrollment, all Medicare participants have the opportunity to change Medicare plans or add or drop coverage. Outside of the open enrollment period, there are not many opportunities for current Medicare participants to change their coverage. Medicare plans may adjust which medications and

PHA Recognizes Respiratory Care Week

2018-10-19T21:08:49+00:00 October 19th, 2018|

In recognition of Respiratory Care Week Oct. 21-27, the Pulmonary Hypertension Association (PHA) interviewed a registered respiratory therapist and certified pulmonary function technician. Tonya Zeiger, R.R.T., CPFT, is the pulmonary hypertension (PH) coordinator and associate in pulmonary medicine at the Mayo Clinic’s Jacksonville, Fla. campus, a PHA-accredited Center of Comprehensive Care (CCC). In this interview,

Two Pulmonary Hypertension Programs Receive PHA’s PHCC Accreditation

2018-09-28T16:31:37+00:00 September 28th, 2018|

The Pulmonary Hypertension Association’s (PHA’s) Pulmonary Hypertension Care Center (PHCC) program granted Regional Care Program (RCP) accreditation to the Pulmonary Hypertension Program at Northside Hospital in Atlanta, and the Pulmonary Hypertension Clinic at Baylor Scott & White The Heart Hospital – Plano, in Plano, Texas, this month. PHA created the PHCC accreditation program in

Make the Most of Your Health Insurance: Prepare Now for Open Enrollment

2018-09-14T20:40:03+00:00 September 14th, 2018|

Most types of health insurance limit when participants may enroll or make changes to their coverage. During most of the year, changes and additions are restricted to major life events such as losing a job, getting married or having a child. Open enrollment, or annual enrollment, is a period of time each year when

Navigating Access to Generic Therapy

2018-09-14T20:44:07+00:00 September 14th, 2018|

The Pulmonary Hypertension Association (PHA) reported Aug. 17 that generic tadalafil was approved by the Food and Drug Administration (FDA) and suggested that pulmonary hypertension (PH) patients taking Adcirca® discuss the implications with their care teams. Since then, generic tadalafil has become available through many health insurance plans. In addition, PHA has been advised

Share Your Oxygen Experiences: PHA Responds to Proposed Changes to Medicare Oxygen Coverage

2018-11-05T13:47:03+00:00 September 7th, 2018|

The Centers for Medicare and Medicaid Services (CMS) has proposed significant changes to how home oxygen (also known as supplemental oxygen) is regulated and paid for. The Pulmonary Hypertension Association (PHA) is taking action to improve the pulmonary hypertension (PH) community’s experience accessing home oxygen. If you have been prescribed home oxygen, you can help

Examination of PHAR Data Shows Few Patients are Referred to Palliative Care

2018-08-31T15:42:34+00:00 August 31st, 2018|

Although treatment options for WHO Group 1 PH (pulmonary arterial hypertension, or PAH) have increased over the past few decades, symptom severity and quality of life still impose significant burden on patients. Palliative care – often confused with hospice care – is goal-oriented care for patients with chronic illnesses that help to balance life-saving

Caution: Accumulator Adjustment Programs at Work

2018-08-31T15:46:44+00:00 August 30th, 2018|

Accumulator adjustment programs are a cost-management strategy some pharmacy benefit managers (PBMs) are using that may place a significant financial burden on individuals with pulmonary hypertension (PH) and other complex, costly health conditions. When an insurance plan uses an accumulator adjustment program, copay discount cards and other forms of manufacturer assistance do not apply

FDA Approves Generic Version of Adcirca®; Additional Approvals May Come Soon

2018-08-21T13:45:25+00:00 August 17th, 2018|

The Pulmonary Hypertension Association (PHA) recently learned that the Food and Drug Administration (FDA) has approved a generic version of tadalafil, the pulmonary arterial hypertension (PAH)-targeted therapy sold as Adcirca®. Availability of the generic therapy for patients remains to-be-determined. PHA also has been advised that generic versions of other PAH-targeted therapies may become available soon.